SOLESENCE INC (SLSN)

What SOLESENCE INC does

Solésence develops and manufactures engineered particle materials, coatings, and formulations for use in sunscreen lotions, cosmetics, and personal care products. The company operates two manufacturing and research facilities in the Chicago area—a 36,000 square-foot headquarters and R&D facility in Romeoville, Illinois, and a 261,000 square-foot production and warehouse facility in Bolingbrook, Illinois. Its manufacturing processes are registered under FDA, ISO 9001, ISO 22716, and ISO 14001 standards. The company generates revenue through the sale of particle-based ingredients and fully formulated sunscreen and cosmetic products to brand partners.

Fundamentals

• Price$0.70 as of 2026-07-09 close
• Market cap$49M as of 2026-07-10
• 1-year return-81.5% as of 2026-07-09 close
• P/E52.10 as of 2026-07-10
• Net margin+1.6% as of 2026-07-10
• Gross margin+26.5% as of 2026-07-10
• ROE+5.4% as of 2026-07-10
• Debt / equity0.80 as of 2026-07-10
• Revenue growth (YoY)+5.8% as of 2026-07-10
• Revenue CAGR (3y)+18.5% SEC XBRL
• Beta1.31 as of 2026-07-10

Ask why SLSN looks like this →

Key risks (from latest filing)

["Significant revenue decline and operating losses: Q1 2026 revenue dropped 11.4% YoY and the company posted a net loss of $766K; accumulated deficit stands at $99.4M as of March 2026.","Weak cash position and reliance on related-party financing: Cash fell to $573K as of March 2026, with $12.5M in outstanding related-party credit lines and debt; limited liquidity headroom.","Dependence on limited customer base and market acceptance: Revenue generation relies on customer acceptance and demand for engineered particle materials and formulated products, with no diversified customer revenue base disclosed."]

See SLSN's biggest risks from its latest 10-Q →